MBX Biosciences (MBX) Competitors $16.51 +0.27 (+1.66%) (As of 11/21/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends MBX vs. WVE, KROS, AKRO, AMPH, MIRM, CNTA, SUPN, MNKD, EVO, and HRMYShould you be buying MBX Biosciences stock or one of its competitors? The main competitors of MBX Biosciences include Wave Life Sciences (WVE), Keros Therapeutics (KROS), Akero Therapeutics (AKRO), Amphastar Pharmaceuticals (AMPH), Mirum Pharmaceuticals (MIRM), Centessa Pharmaceuticals (CNTA), Supernus Pharmaceuticals (SUPN), MannKind (MNKD), Evotec (EVO), and Harmony Biosciences (HRMY). These companies are all part of the "pharmaceutical preparations" industry. MBX Biosciences vs. Wave Life Sciences Keros Therapeutics Akero Therapeutics Amphastar Pharmaceuticals Mirum Pharmaceuticals Centessa Pharmaceuticals Supernus Pharmaceuticals MannKind Evotec Harmony Biosciences MBX Biosciences (NYSE:MBX) and Wave Life Sciences (NASDAQ:WVE) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation, dividends and community ranking. Does the MarketBeat Community prefer MBX or WVE? Wave Life Sciences received 359 more outperform votes than MBX Biosciences when rated by MarketBeat users. However, 100.00% of users gave MBX Biosciences an outperform vote while only 67.85% of users gave Wave Life Sciences an outperform vote. CompanyUnderperformOutperformMBX BiosciencesOutperform Votes4100.00% Underperform VotesNo VotesWave Life SciencesOutperform Votes36367.85% Underperform Votes17232.15% Which has higher earnings & valuation, MBX or WVE? MBX Biosciences has higher earnings, but lower revenue than Wave Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMBX BiosciencesN/AN/AN/AN/AN/AWave Life Sciences$113.31M19.32-$57.51M-$1.11-12.93 Is MBX or WVE more profitable? MBX Biosciences has a net margin of 0.00% compared to Wave Life Sciences' net margin of -66.50%. MBX Biosciences' return on equity of 0.00% beat Wave Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets MBX BiosciencesN/A N/A N/A Wave Life Sciences -66.50%-280.57%-52.90% Do analysts rate MBX or WVE? MBX Biosciences presently has a consensus price target of $37.25, suggesting a potential upside of 125.62%. Wave Life Sciences has a consensus price target of $22.22, suggesting a potential upside of 54.86%. Given MBX Biosciences' higher possible upside, research analysts plainly believe MBX Biosciences is more favorable than Wave Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MBX Biosciences 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of MBX or WVE? 89.7% of Wave Life Sciences shares are owned by institutional investors. 29.1% of Wave Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media refer more to MBX or WVE? In the previous week, Wave Life Sciences had 29 more articles in the media than MBX Biosciences. MarketBeat recorded 37 mentions for Wave Life Sciences and 8 mentions for MBX Biosciences. Wave Life Sciences' average media sentiment score of 0.46 beat MBX Biosciences' score of -0.04 indicating that Wave Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MBX Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Wave Life Sciences 6 Very Positive mention(s) 1 Positive mention(s) 11 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryWave Life Sciences beats MBX Biosciences on 8 of the 13 factors compared between the two stocks. Ad Genesis Gold GroupBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now Get MBX Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBX vs. The Competition Export to ExcelMetricMBX BiosciencesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$551.76M$6.58B$5.14B$20.11BDividend YieldN/A8.11%5.05%3.49%P/E RatioN/A10.93132.3743.37Price / SalesN/A363.851,231.9918.40Price / CashN/A52.5940.0621.28Price / BookN/A10.176.954.65Net IncomeN/A$153.36M$119.48M$985.54M7 Day Performance-15.29%-1.62%-1.43%1.71%1 Month Performance-30.89%-7.16%-3.34%2.29%1 Year PerformanceN/A31.66%32.33%26.45% MBX Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBXMBX Biosciences1.9049 of 5 stars$16.51+1.7%$37.25+125.6%N/A$551.76MN/A0.0036WVEWave Life Sciences4.8643 of 5 stars$14.35+0.6%$22.22+54.9%+174.2%$2.19B$113.31M-12.85240Analyst ForecastAnalyst RevisionKROSKeros Therapeutics3.551 of 5 stars$53.84-0.6%$88.89+65.1%+80.5%$2.18B$150,000.00-10.33100AKROAkero Therapeutics4.0591 of 5 stars$31.20+1.8%$46.83+50.1%+83.8%$2.18BN/A-8.3230Analyst ForecastInsider TradeAMPHAmphastar Pharmaceuticals4.8286 of 5 stars$44.47+0.9%$63.00+41.7%-22.1%$2.14B$644.40M14.721,761Positive NewsMIRMMirum Pharmaceuticals4.3261 of 5 stars$43.48-0.5%$57.73+32.8%+36.1%$2.09B$186.37M-21.52140Analyst RevisionCNTACentessa Pharmaceuticals4.0723 of 5 stars$18.19+8.7%$25.83+42.0%+144.7%$2.06B$6.85M-11.8972Positive NewsSUPNSupernus Pharmaceuticals2.5287 of 5 stars$35.82-0.8%$36.00+0.5%+32.3%$1.99B$651.97M33.48580Positive NewsMNKDMannKind3.7406 of 5 stars$6.90+0.3%$8.67+25.6%+83.0%$1.90B$198.96M98.61400Insider TradeEVOEvotec1.9421 of 5 stars$5.35+0.9%$5.93+10.9%-49.7%$1.90B$845.74M0.005,061HRMYHarmony Biosciences4.7625 of 5 stars$33.23+1.3%$47.00+41.4%+18.1%$1.90B$582.02M15.64200 Related Companies and Tools Related Companies Wave Life Sciences Competitors Keros Therapeutics Competitors Akero Therapeutics Competitors Amphastar Pharmaceuticals Competitors Mirum Pharmaceuticals Competitors Centessa Pharmaceuticals Competitors Supernus Pharmaceuticals Competitors MannKind Competitors Evotec Competitors Harmony Biosciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:MBX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
